Scientists develop first drug-like compounds to inhibit elusive cancer-linked enzymes
Monday, August 31, 2020 - 16:00
in Biology & Nature
Structural biology techniques helped researchers target the nuclear receptor-binding SET domain family for the first time; its malfunction is associated with several types of cancer.